Trends and predictors of non-AIDS-defining cancers in men and women with HIV infection: A single-institution retrospective study before and after the introduction of HAART

Journal of Acquired Immune Deficiency Syndromes

Volumn 62, Issue 4, 2013, Pages 414-420

  Franzetti, Marco ^a   Adorni, Fulvio ^b   Parravicini, Carlo ^a   Vergani, Barbara ^a   Antinori, Spinello ^a   Milazzo, Laura ^a   Galli, Massimo ^a   Ridolfo, Anna Lisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b INSTITUTE OF BIOMEDICAL TECHNOLOGIES   (Italy)

Author keywords

Antiretroviral therapy; HIV infection; Non AIDS defining cancers

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ANUS CANCER; ARTICLE; BLADDER CANCER; BONE CANCER; BRAIN CANCER; BREAST CANCER; CANCER DIAGNOSIS; CANCER REGISTRY; CANCER RISK; COLON CANCER; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HODGKIN DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFORMATION; KIDNEY CANCER; LARYNX CANCER; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEOPLASM; NON AIDS DEFINING CANCER; OVARY CANCER; PANCREAS CANCER; POPULATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; RETROSPECTIVE STUDY; SMOKING; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; TESTIS CANCER; THYROID CANCER; TONGUE CANCER; TONSIL CANCER; VULVA CANCER;

EID: 85028118302     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318282a189     Document Type: Article

References (45)

1. Goedert JJ, Cot TR, Virgo P, et al. Spectrum of AIDS-associated malignant disorders. Lancet. 1998;351:1833-1839.
2. Centers for Disease Control and Prevention, 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41: 1-19.
3. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 853-860.
4. Bedimo R, Chen RY, Accortt NA, et al. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989- 2002. Clin Infect Dis. 2004;39:1380-1384.
5. Hessol NA, Pipkin S, Schwarcz S, et al. The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol. 2007;165:1143-1153.
6. Long JL, Engels EA, Moore RD, et al. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008;22:489-496.
7. Patel P, Hanson DL, Sullivan PS, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148:729-738.
8. Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009;23:41-50.
9. Shiels MS, Cole SR, Kirk GD, et al. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009;52:611-622.
10. Zucchetto A, Suligoi B, De Paoli A, et al. Excess mortality for non-AIDS defining cancers among people with AIDS. Clin Infect Dis. 2010;51: 1099-1101.
11. Finkel T, Serrano M, Blasco MA. The common biology of cancer and ageing. Nature. 2007;448:767-774.
12. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis. 1998;177:361-367.
13. Palefsky JM, Holly EA, Ralston ML, et al. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis. 2001; 183:383-391.
14. Vallet-Pichard A, Pol S. Hepatitis viruses and human immunodeficiency virus co-infection: pathogenesis and treatment. J Hepatol. 2004; 41:156-166.
15. Tesoriero JM, Gieryic SM, Carrascal A, et al. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS Behav. 2010;14:824-835.
16. Blattner WA. Human retroviruses: their role in cancer. Proc Assoc Am Physicians. 1999;111:563-572.
17. Grulich AE, van Leeuwen MT, Falster MO, et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67.
18. World Health Organization. IARC Monographs on Evaluation of Carcinogenic Risk to Humans, Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents. Lyon, France: International Agency for Research on Cancer; 2000:35-127. Publication No. 76.
19. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents; 2011. Washington DC: U.S. Department of Health and Human Sciences. Available at: http://www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed October 14, 2011.
20. Russo A, Bisanti L. Rapporto a Milano. Milan Cancer sui tumori Report. Milan, Italy: Azienda Sanitaria Locale della Città di Milano. Servizio di Epidemiologia; 2007. Available at: http://www.registri-tumori.it/cms/?q= RTMilano. Accessed June 15, 2011.
21. Deeken JF, Tjen-A-Looi A, Rudek MA, et al. The rising challenge of non-AIDS defining cancers in HIV-infected patients. Clin Infect Dis. 2012;55:1228-1235.
22. Frisch M, Biggar RJ, Engels EA, et al; AIDS-Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. JAMA. 2001;285:1736-1745.
23. Clifford GM, Polesel J, Rickenbach M, et al. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst. 2005;97: 425-432.
24. Kesselring A, Gras L, Smit C, et al. Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapy. Clin Infect Dis. 2011;52: 1458-1465.
25. Reekie J, Kosa C, Engsig F, et al. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies. Cancer. 2010;116:5306-5315.
26. Burgi A, Brodine S, Wegner S, et al. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals. Cancer. 2005;104:1505-1511.
27. Crum-Cianflone NF, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: authors' reply. AIDS. 2009;23:1791-1792.
28. Spina M, Carbone A, Gloghini A, et al. Hodgkin's disease in patients with HIV infection. Adv Hematol. 2011;2011:402682.
29. Biggar RJ, Jaffe ES, Goedert JJ, et al. Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood. 2006;108:3786-3791.
30. Righetti E, Ballon G, Ometto L, et al. Dynamics of Epstein-Barr virus in HIV-1-infected subjects on highly active antiretroviral therapy. AIDS. 2002;16:63-73.
31. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr. 1998;23:15-20.
32. Palefsky JM, Holly EA, Ralston ML, et al. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr. 2001;28:422-428.
33. Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr. 2004;37: 1563-1565.
34. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst. 2000;92: 1500-1510.
35. Mork J, Lie AK, Glattre E, et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med. 2001;344:1125-1131.
36. Kreimer AR, Alberg AJ, Daniel R, et al. Oral human papillomavirus infection in adults is associated with sexual behavior and HIV serostatus. J Infect Dis. 2004;189:686-698.
37. Joshi D, O'Grady J, Dieterich D, et al. Increasing burden of hepatocellular disease in patients with HIV infection. Lancet. 2011;377:1198-1209.
38. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012;142:1264-1273.
39. Clifford GM, Lise M, Franceschi S, et al; the Swiss HIV Cohort Study. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer. 2012;106:447-452.
40. Levine AM, Seaberg EC, Hessol NA, et al. HIV as a risk factor for lung cancer in women: data from the Women's Interagency HIV Study. J Clin Oncol. 2010;28:1514-1519.
41. Franceschi S, Dal Maso L, Arniani S, et al. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer. 1998; 78:966-970.
42. Newnham A, Harris J, Evans HS, et al. The risk of cancer in HIVinfected people in southeast England: a cohort study. Br J Cancer. 2005;92:194-200.
43. Cooksley CD, Hwang LY, Waller DK, et al. HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data. Int J STD AIDS. 1999;10:795-802.
44. Dal Maso L, Polesel J, Serraino D, et al. Pattern of cancer risk in persons with AIDS in Italy in the HAART era. Br J Cancer. 2009; 100:840-847.
45. Herida M, Mary-Krause M, Kaphan R, et al. Incidence of non-AIDSdefining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients. J Clin Oncol. 2003;21:3447-3453.